Nociceptive tolerance is improved by bradykinin receptor B1 antagonism and joint morphology is protected by both endothelin type A and bradykinin receptor B1 antagonism in a surgical model of osteoarthritis

Abstract

IntroductionEndothelin-1, a vasoconstrictor peptide, influences cartilage metabolism mainly via endothelin receptor type A (ETA). Along with the inflammatory nonapeptide vasodilator bradykinin (BK), which acts via bradykinin receptor B1 (BKB1) in chronic inflammatory conditions, these vasoactive factors potentiate joint pain and inflammation. We describe a preclinical study of the efficacy of treatment of surgically induced osteoarthritis with ETA and/or BKB1 specific peptide antagonists. We hypothesize that antagonism of both receptors will diminish osteoarthritis progress and articular nociception in a synergistic manner.MethodsOsteoarthritis was surgically induced in male rats by transection of the right anterior cruciate ligament. Animals were subsequently treated with weekly intra-articular injections of specific peptide antagonists of ETA and/or BKB1. Hind limb nociception was measured by static weight bearing biweekly for two months post-operatively. Post-mortem, right knee joints were analyzed radiologically by X-ray and magnetic resonance, and histologically by the OARSI histopathology assessment system.ResultsSingle local BKB1 antagonist treatment diminished overall hind limb nociception, and accelerated post-operative recovery after disease induction. Both ETA and/or BKB1 antagonist treatments protected joint radiomorphology and histomorphology. Dual ETA/BKB1 antagonism was slightly more protective, as measured by radiology and histology.ConclusionsBKB1 antagonism improves nociceptive tolerance, and both ETA and/or BKB1 antagonism prevents joint cartilage degradation in a surgical model of osteoarthritis. Therefore, they represent a novel therapeutic strategy: specific receptor antagonism may prove beneficial in disease management.

The role of kinin B1receptor and the effect of angiotensin I-converting enzyme inhibition on acute gout attacks in rodents

“…These results are relevant because pain and oedema are hallmark responses of an acute gouty attack in humans 8 9 37. Similar to our findings in a gout model, IA administration of a B 1 R antagonist is able to reduce pain and joint damage in a model of osteoarthritis 38. Additionally, since IA administration is routinely used clinically, it is possible that local administration of B 1 R antagonists could be an effective way to treat gouty attacks in humans 8…”

Puerarin attenuates inflammation and oxidation in mice with collagen antibody-induced arthritis via TLR4/NF-κB signaling

“…The genesis and progression of OA is closely associated with cartilage injuries as a result of arthritis (19). When cells are under inflammatory stress or injured, abnormal mechanical stress results in activation of cartilage cells to stimulate macrophages to produce a series of inflammatory mediators.…”

In-vivo T2-relaxation times of asymptomatic cervical intervertebral discs

“…The exponential decay of average ROI image signal intensity (SI) with increasing echo time (TE) was plotted and a least-squares best fit was applied. The best fit decay curve was modeled with the equation: SI (TE) = M 0 −(TE/T2) , allowing for the calculation of the spin density (M 0 = SI (0)) and T2 relaxation time (T2) for the given ROI 45, 46 .…”